Cardiovascular protective effect of sodium-glucose cotransporter 2 inhibitors on patients with acute coronary syndrome and type 2 diabetes mellitus: a retrospective study

Table 3 Each component of adverse cardiovascular outcomes

	HR (95%CI)	P	*HR(95%CI)**	P*
Adverse cardiovascular outcomes	0.66 (0.35,1.25)	0.195
Rehospitalization for ACS or HF	0.58 (0.30,1.11)	0.095	0.56 (0.28,1.10)	0.093
Rehospitalization for ACS	0.87 (0.40,1.87)	0.713
Rehospitalization for HF	0.18 (0.04,0.84)	0.014	0.20 (0.04,0.96)	0.045
Cardiovascular mortality	1.75 (0.28,10.97)	0.543

Multivariate Cox regression models were used to adjust for results with P < 0.10; HR* and P*, HR and P values after adjusting for potential confounders, including age, CAD, LAD, and hypertension

ISSN: 1471-2261